BACKGROUND: Aberrant mucosal immune responses to antigens of the resident microbiota are a significant cause of inflammatory bowel diseases (IBD), as are genetic and environmental factors. Previous work from our laboratory demonstrated that Helicobacter bilis colonization of immunocompetent, defined microbiota mice induced antigen-specific immune responses to the resident microbiota, yet these mice failed to develop colitis, suggesting that the immunological provocation induced by H. bilis alone was insufficient to induce disease. AIM: The purpose of this study was to test the hypothesis that the introduction of a bacterial provocateur such as H. bilis enhances the host's susceptibility to IBD following an inflammatory event. METHODS: Defined microbiota (DM) mice colonized with H. bilis were administered low dose (1.5%) dextran sodium sulfate (DSS) in drinking water for 5 days followed by a 4-day restitution period. Severity of lesions was assessed grossly and microscopically. Differential expression of select mucosal genes and histopathologic lesions was characterized. RESULTS: Helicobacter bilis colonization increased the severity of intestinal inflammation induced by an inflammatory trigger in the form of low-dose DSS. An analysis of the molecular and cellular mechanisms associated with H. bilis colonization revealed significant increases in expression of mucosal genes associated with lymphocyte activation and inflammatory cell chemotaxis as well as increased infiltration of mucosal macrophages and T cells in mice colonized with H. bilis prior to DSS treatment versus DSS treatment alone. CONCLUSIONS: These results indicate that prior colonization with H. bilis heightens the host's sensitivity to enteric inflammation by altering mucosal homeostasis and initiating immune cell activation and migration.
BACKGROUND: Aberrant mucosal immune responses to antigens of the resident microbiota are a significant cause of inflammatory bowel diseases (IBD), as are genetic and environmental factors. Previous work from our laboratory demonstrated that Helicobacter bilis colonization of immunocompetent, defined microbiota mice induced antigen-specific immune responses to the resident microbiota, yet these mice failed to develop colitis, suggesting that the immunological provocation induced by H. bilis alone was insufficient to induce disease. AIM: The purpose of this study was to test the hypothesis that the introduction of a bacterial provocateur such as H. bilis enhances the host's susceptibility to IBD following an inflammatory event. METHODS: Defined microbiota (DM) mice colonized with H. bilis were administered low dose (1.5%) dextran sodium sulfate (DSS) in drinking water for 5 days followed by a 4-day restitution period. Severity of lesions was assessed grossly and microscopically. Differential expression of select mucosal genes and histopathologic lesions was characterized. RESULTS:Helicobacter bilis colonization increased the severity of intestinal inflammation induced by an inflammatory trigger in the form of low-dose DSS. An analysis of the molecular and cellular mechanisms associated with H. bilis colonization revealed significant increases in expression of mucosal genes associated with lymphocyte activation and inflammatory cell chemotaxis as well as increased infiltration of mucosal macrophages and T cells in mice colonized with H. bilis prior to DSS treatment versus DSS treatment alone. CONCLUSIONS: These results indicate that prior colonization with H. bilis heightens the host's sensitivity to enteric inflammation by altering mucosal homeostasis and initiating immune cell activation and migration.
Authors: G Schumacher; B Kollberg; B Sandstedt; C Jorup; L Grillner; A Ljungh; R Möllby Journal: Scand J Gastroenterol Date: 1993-12 Impact factor: 2.423
Authors: Albert E Jergens; Andrea Dorn; Jenny Wilson; Krystal Dingbaum; Abigail Henderson; Zhiping Liu; Jesse Hostetter; Richard B Evans; Michael J Wannemuehler Journal: Microbes Infect Date: 2006-04-18 Impact factor: 2.700
Authors: A Burich; R Hershberg; K Waggie; W Zeng; T Brabb; G Westrich; J L Viney; L Maggio-Price Journal: Am J Physiol Gastrointest Liver Physiol Date: 2001-09 Impact factor: 4.052
Authors: Seung G Kang; Ronald J Piniecki; Harm Hogenesch; Hyung W Lim; Eric Wiebke; Stephen E Braun; Satoshi Matsumoto; Chang H Kim Journal: Gastroenterology Date: 2007-01-05 Impact factor: 22.682
Authors: M A Musci; L R Hendricks-Taylor; D G Motto; M Paskind; J Kamens; C W Turck; G A Koretzky Journal: J Biol Chem Date: 1997-05-02 Impact factor: 5.157
Authors: Chad K Porter; David R Tribble; Pablo A Aliaga; Heather A Halvorson; Mark S Riddle Journal: Gastroenterology Date: 2008-06-05 Impact factor: 22.682
Authors: Georgina L Hold; Megan Smith; Charlie Grange; Euan Robert Watt; Emad M El-Omar; Indrani Mukhopadhya Journal: World J Gastroenterol Date: 2014-02-07 Impact factor: 5.742
Authors: Sureshkumar Muthupalani; Zhongming Ge; Yan Feng; Barry Rickman; Melissa Mobley; Amanda McCabe; Nico Van Rooijen; James G Fox Journal: Infect Immun Date: 2012-10-01 Impact factor: 3.441
Authors: Grace M Hudson; Kyle L Flannigan; Sarah L Erickson; Fernando A Vicentini; Alexandra Zamponi; Christina L Hirota; Laurie Alston; Christophe Altier; Subrata Ghosh; Kevin P Rioux; Sridhar Mani; Thomas K Chang; Simon A Hirota Journal: Br J Pharmacol Date: 2017-04-19 Impact factor: 8.739
Authors: João Carlos Gomes-Neto; Sara Mantz; Kyler Held; Rohita Sinha; Rafael R Segura Munoz; Robert Schmaltz; Andrew K Benson; Jens Walter; Amanda E Ramer-Tait Journal: J Microbiol Methods Date: 2017-02-09 Impact factor: 2.363
Authors: Meghan Wymore Brand; Michael J Wannemuehler; Gregory J Phillips; Alexandra Proctor; Anne-Marie Overstreet; Albert E Jergens; Roger P Orcutt; James G Fox Journal: ILAR J Date: 2015